Literature DB >> 32173491

Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.

Rudolf K F Oliveira1, Aaron B Waxman2, Paul J Hoover3, Paul F Dellaripa3, David M Systrom4.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) adversely affects patient's exercise capacity in interstitial lung disease (ILD). The impact of pulmonary vascular and right ventricular (RV) dysfunction, however, has traditionally been believed to be mild and clinically relevant principally in advanced lung disease states. RESEARCH QUESTION: The aim of this study was to evaluate the relative contributions of pulmonary mechanics, pulmonary vascular function, and RV function to the ILD exercise limit. STUDY DESIGN AND METHODS: Forty-nine patients with ILD who underwent resting right heart catheterization followed by invasive exercise testing were evaluated. Patients with PH at rest (ILD + rPH) and with PH diagnosed exclusively during exercise (ILD + ePH) were contrasted with ILD patients without PH (ILD non-PH).
RESULTS: Peak oxygen consumption was reduced in ILD + rPH (61 ± 10% predicted) and ILD + ePH (67 ± 13% predicted) compared with ILD non-PH (81 ± 16% predicted; P < .001 and P = .016, respectively). Each ILD hemodynamic phenotype presented distinct patterns of dynamic changes of pulmonary vascular compliance relative to pulmonary vascular resistance from rest to peak exercise. Peak RV stroke work index was increased in ILD + ePH (24.7 ± 8.2 g/m2 per beat) and ILD + rPH (30.9 ± 6.1 g/m2 per beat) compared with ILD non-PH (18.3 ± 6.4 g/m2 per beat; P = .020 and P = .014). Ventilatory reserve was reduced in ILD + rPH compared with the other groups at the anaerobic threshold, but it was similar between ILD + ePH and ILD non-PH at the anaerobic threshold (0.32 ± 0.13 vs 0.30 ± 0.11; P = .921) and at peak exercise (0.70 ± 0.17 vs 0.73 ± 0.24; P = .872).
INTERPRETATION: ILD with resting and exercise PH is associated with increased exercise RV work, reduced pulmonary vascular reserve, and reduced peak oxygen consumption. The findings highlight the role of pulmonary vascular and RV burden to ILD exercise limit.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  exercise; hemodynamics; interstitial lung disease; pulmonary hypertension; right ventricle

Mesh:

Year:  2020        PMID: 32173491      PMCID: PMC8173767          DOI: 10.1016/j.chest.2020.02.043

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  50 in total

Review 1.  Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia.

Authors:  Lauren K Troy; Iven H Young; Edmund M T Lau; Tamera J Corte
Journal:  Respirology       Date:  2015-09-29       Impact factor: 6.424

2.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Respir J       Date:  2015-08-29       Impact factor: 16.671

3.  Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects.

Authors:  Bart G Boerrigter; Aaron B Waxman; Nico Westerhof; Anton Vonk-Noordegraaf; David M Systrom
Journal:  Eur Respir J       Date:  2013-10-31       Impact factor: 16.671

4.  The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension.

Authors:  Onno A Spruijt; Frances S de Man; Herman Groepenhoff; Frank Oosterveer; Nico Westerhof; Anton Vonk-Noordegraaf; Harm-Jan Bogaard
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

5.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Authors:  Bradley A Maron; Edward Hess; Thomas M Maddox; Alexander R Opotowsky; Ryan J Tedford; Tim Lahm; Karen E Joynt; Daniel J Kass; Thomas Stephens; Maggie A Stanislawski; Erik R Swenson; Ronald H Goldstein; Jane A Leopold; Roham T Zamanian; Jean M Elwing; Mary E Plomondon; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Gaurav Choudhary
Journal:  Circulation       Date:  2016-02-12       Impact factor: 29.690

6.  Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis.

Authors:  Mart N van der Plas; Coen van Kan; Judith Blumenthal; Henk M Jansen; Athol U Wells; Paul Bresser
Journal:  Respirology       Date:  2013-11-20       Impact factor: 6.424

7.  Reduced haemodynamic coupling and exercise are associated with vascular stiffening in pulmonary arterial hypertension.

Authors:  Alessandro Bellofiore; Eric Dinges; Robert Naeije; Hamorabi Mkrdichian; Lauren Beussink-Nelson; Melissa Bailey; Michael J Cuttica; Ranya Sweis; James R Runo; Jon G Keevil; Christopher J Francois; Sanjiv J Shah; Naomi C Chesler
Journal:  Heart       Date:  2016-08-26       Impact factor: 5.994

8.  Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

Authors:  Stephen C Mathai; Laura K Hummers; Hunter C Champion; Fredrick M Wigley; Ari Zaiman; Paul M Hassoun; Reda E Girgis
Journal:  Arthritis Rheum       Date:  2009-02

9.  High Right Ventricular Stroke Work Index Is Associated with Worse Kidney Function in Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Napatt Kanjanahattakij; Natee Sirinvaravong; Francisco Aguilar; Akanksha Agrawal; Parasuram Krishnamoorthy; Shuchita Gupta
Journal:  Cardiorenal Med       Date:  2018-02-28       Impact factor: 2.041

10.  Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.

Authors:  Robin Condliffe; David G Kiely; Andrew J Peacock; Paul A Corris; J Simon R Gibbs; Florenc Vrapi; Clare Das; Charlie A Elliot; Martin Johnson; Julia DeSoyza; Chantal Torpy; Kim Goldsmith; Denise Hodgkins; Rodney J Hughes; Joanna Pepke-Zaba; J Gerry Coghlan
Journal:  Am J Respir Crit Care Med       Date:  2008-10-17       Impact factor: 21.405

View more
  1 in total

Review 1.  Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology.

Authors:  Michael H Lee; Thaís C F Menezes; Julie A Reisz; Eloara V M Ferreira; Brian B Graham; Rudolf K F Oliveira
Journal:  Front Physiol       Date:  2022-09-12       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.